Eisai is a pharmaceutical company focusing on research, development, and marketing of healthcare products. Founded in 1995 as a subsidiary of Tokyo-based Eisai Co., Ltd., the company has since grown rapidly to become an integrated pharmaceutical business in the United States. Headquartered in Woodcliff Lake, New Jersey, Eisai is dedicated to addressing the diverse healthcare needs of patients and their families, while also maintaining a strong commitment to the U.S. market. Recognized as an innovative and solution-oriented company, Eisai forms strong alliances that give it a competitive edge in the industry.
With 1,864 employees and an annual revenue of $5.3 billion, Eisai boasts a diverse workforce that personifies its values of integrity, respect, professionalism, quality, and teamwork. The company's staff has a high retention rate, with employees staying for an average of 5.4 years. Although salaries at Eisai are comparatively lower than some competitors like AstraZeneca and Novartis, the company remains a leader in the pharmaceutical industry under CEO Haruo Naito.
